J 2018

Low-dose versus standard-dose azithromycin for treatment of yaws

PAŠTĚKOVÁ, Lenka and David ŠMAJS

Basic information

Original name

Low-dose versus standard-dose azithromycin for treatment of yaws

Authors

PAŠTĚKOVÁ, Lenka (203 Czech Republic, guarantor, belonging to the institution) and David ŠMAJS (203 Czech Republic, belonging to the institution)

Edition

LANCET GLOBAL HEALTH, OXFORD, ELSEVIER SCI LTD, 2018, 2214-109X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 15.873

RIV identification code

RIV/00216224:14110/18:00102804

Organization unit

Faculty of Medicine

DOI

UT WoS

000427125900004

Keywords in English

azithromycin

Tags

Tags

International impact, Reviewed
Změněno: 23/4/2024 10:00, Mgr. Michal Petr

Abstract

V originále

In their Article in The Lancet Global Health, Michael Marks and colleagues1 compare the efficacy of low-dose azithromycin (20 mg/kg) versus standard-dose azithromycin (30 mg/kg) for the treatment of yaws. The lower dose of azithromycin is commonly used for trachoma elimination and, since yaws and trachoma are co-endemic in several regions,2 mass treatment with low-dose azithromycin could also aid yaws eradication. If a low-dose azithromycin treatment is as effective against yaws as standard-dose azithromycin, yaws eradication programmes can expect a considerable cost saving.